These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 9106248)

  • 1. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.
    Penman BW; Chen L; Gelboin HV; Gonzalez FJ; Crespi CL
    Carcinogenesis; 1994 Sep; 15(9):1931-7. PubMed ID: 7923587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase.
    Fujita K; Nakayama K; Yamazaki Y; Tsuruma K; Yamada M; Nohmi T; Kamataki T
    Environ Mol Mutagen; 2001; 38(4):329-38. PubMed ID: 11774365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
    Yamazaki H; Shimada T
    Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
    Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS
    Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
    Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
    Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
    Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate.
    Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():85-90. PubMed ID: 16719376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates.
    Mankowski DC; Lawton MP; Ekins S
    Xenobiotica; 2000 Aug; 30(8):745-54. PubMed ID: 11037108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus.
    Henderson MC; Miranda CL; Stevens JF; Deinzer ML; Buhler DR
    Xenobiotica; 2000 Mar; 30(3):235-51. PubMed ID: 10752639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alachlor on hepatic cytochrome P450 enzymes in rats.
    Hanioka N; Watanabe K; Yoda R; Ando M
    Drug Chem Toxicol; 2002 Feb; 25(1):25-37. PubMed ID: 11850968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
    Kao LR; Wilkinson CF
    Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
    Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
    Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.